Cash and Investments: $22 billion
Annual Operating Cash Flow: $5.9 billion
Revenue Per Employee: $978,000
Biotech blue chip Amgen (AMGN) is in a great position for stability simply by virtue of its sector of focus.
Healthcare is one of the most recession-proof industries out there, since sickness can strike no matter what the macroeconomic environment. Even in tough times, folks will cut back on everything else before they stop buying medications that keep them healthy and improve the quality of their lives.
But if you need even more reasons to invest in Amgen, take a look at the cash stockpile and the robust cash flow for more peace of mind.